Bevacizumab-Teva 100 mg/4 ml
Bevacizumab-Teva 100 mg/4 ml is a medicine authorised by Swissmedic under authorisation number 67886. The authorisation holder is Teva Pharma AG. The medicinal product code is Biotechnological medicines and the dispensing category is A: Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly. First authorisation was granted on 10 May 2021 and the authorisation is valid without a time limit. ATC code L01FG01 places the medicine in the group Antineoplastic agents.
| Authorisation number | 67886 |
|---|---|
| Name | Bevacizumab-Teva 100 mg/4 ml |
| Full name | Bevacizumab-Teva 100 mg/4 ml, Konzentrat zur Herstellung einer Infusionslösung |
| Authorisation holder | Teva Pharma AG |
| Medicinal product code | Biotechnological medicines |
| Dispensing category | A · Prescription, not repeatable |
| ATC code | L01FG01 |
| First authorisation | 10 May 2021 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Bevacizumab-Teva 100 mg/4 ml, Konzentrat zur Herstellung einer Infusionslösung | A | 10 May 2021 |
| 2 | Bevacizumab-Teva 400 mg/16 ml, Konzentrat zur Herstellung einer Infusionslösung | A | 10 May 2021 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 1 | Durchstechflasche(n) | L01FG01 | 07.16.1. | A |
| 2 | 1 | Durchstechflasche(n) | L01FG01 | 07.16.1. | A |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Bevacizumab-Teva 100 mg/4 ml authorised in Switzerland?
Yes. Bevacizumab-Teva 100 mg/4 ml is authorised by Swissmedic under authorisation number 67886, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Bevacizumab-Teva 100 mg/4 ml have?
Bevacizumab-Teva 100 mg/4 ml is in dispensing category A. Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly.
Who is the authorisation holder of Bevacizumab-Teva 100 mg/4 ml?
The authorisation holder is Teva Pharma AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.